Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Therapeutic Advances in Medical Oncology|January 22, 2024
Treatment options for HER2-expressing colorectal cancer: updates and recent approvalsBinbin Zheng-Lin, Tanios S Bekaii-Saab
Clinical Advances in Hematology & Oncology : H&O|July 1, 2025
The promise of molecular residual disease (MRD) testing for patients with colorectal cancerTanios S Bekaii-Saab, Robert E Schoen
Oncotargets and Therapy|May 10, 2011
New developments in the treatment of metastatic gastric cancer: focus on trastuzumabJeffrey S Rose, Tanios S Bekaii-Saab
Clinical Advances in Hematology & Oncology : H&O|March 28, 2006
Updates and controversies in the treatment of pancreatic cancerKavitha Kosuri, Peter Muscarella, Tanios S Bekaii-Saab
Seminars in Oncology|July 15, 2005
Preclinical experience with docetaxel in gastrointestinal cancersTanios S Bekaii-Saab, Miguel A Villalona-Calero
Clinical Advances in Hematology & Oncology : H&O|May 28, 2024
Improving survival in metastatic colorectal cancer through optimized patient selectionTanios S Bekaii-Saab, Afsaneh Barzi, Mike Cusnir
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
How quality of life can inform management decisions in later-line metastatic colorectal cancerTanios S Bekaii-Saab, Kanwal Raghav, Zev A Wainberg
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Transitioning from second-line to third-line therapy in metastatic colorectal cancerJohn L Marshall, Fotios Loupakis, Tanios S Bekaii-Saab
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 20, 2022
Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinomaBenjamin E Ueberroth, Jeremy C Jones, Tanios S Bekaii-Saab
Pageof 10